Skip to content

Added Value of N Acetyle Cysteine to Clomiphene Citrate in PCO

The Added Value of n Acetyle Cysteine and Chromium to Clomiphene Citrate in PCO

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04170439
Enrollment
108
Registered
2019-11-20
Start date
2019-11-20
Completion date
2020-05-15
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCO

Brief summary

PCO is one of the factors associated with delayed conception

Detailed description

In an attempt to induce ovulation Clomiphene citrate can be given in conjunction with N acetyle cysteine

Interventions

DRUGClomiphene plus metformin plus N acetyle cysteine in arm number 1

oral adminstration of clomiphene citrate plus metformin plus N acetyl cysteine or chromium

DRUGClomiphene citrate plus metformin with chromium

oral adminstration of clomiphene citrate plus metformin and chromium

DRUGclomiphene citrate plus metformin

oral adminstration of clomiphene citrate plus metformin

Sponsors

Cairo University
CollaboratorOTHER
Aljazeera Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Intervention model description

Women who will receive clomiphe citrate plus N acetyle cysteine rally in arm number 1 And women who will receive clomiphene citrate and chromoum in arm number 22

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* women with PCO

Exclusion criteria

* women who donot have PCO

Design outcomes

Primary

MeasureTime frameDescription
The number of women who will have mature follicles wih their size and number of mqture follicles The number of women who will have mature follicleswithin 2 weeksAssessment of women in both groups for size and number of follicles

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026